
Sign up to save your podcasts
Or
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
323 Listeners
98 Listeners
160 Listeners
863 Listeners
496 Listeners
693 Listeners
18 Listeners
274 Listeners
254 Listeners
3,318 Listeners
135 Listeners
1,084 Listeners
7,976 Listeners
186 Listeners
59 Listeners
8 Listeners
424 Listeners
314 Listeners